Skip to content

EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications

CompletedNot applicableNCT03308188
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This is a 10-month internet-based randomized controlled trial to evaluate whether an online chronic pain management program ("E-Health") can assist with reduced opioid reliance in chronic pain patients. About half of the eligible participants will receive access to the E-Health program in addition to their standard chronic pain treatment; the other half will just continue receiving their standard chronic pain treatment.

Study details

Official title
EMPOWER: Evaluating the Ability to Reduce Morphine Equivalent Dose for Chronic Pain Patients Receiving Opioid-therapy Through a Web-based E-Health Self-management Program: a Randomized Multi-site Clinical Trial in Primary Care
Conditions
Interventions
  • Behavioral: E-health program
Sponsor
University of Cincinnati
Collaborators
National Institute on Drug Abuse (NIDA)
Start date
2018-02-05
Primary completion
2021-10-31
Sex
All
Age range
from 25 Years to 80 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Be 25-80 years of age * Be able to understand the study, and having understood, provide informed consent in English * Have a daily average prescribed MED ≥ 20 mg over a recent three-month period * Have a chronic pain-related diagnosis * Self-report current use of opioid medication(s) to treat pain * Have a Brief Pain Inventory Pain Intensity score ≥3 * Have internet access and a working email account Exclusion Criteria: * Be anyone who, in the judgment of study staff, would be unlikely to complete the study (e.g., planning to change to a different primary care clinic, have a terminal illness, etc.) * Be unwilling/unable to complete the WebNeuro assessments * Be pregnant * Be a prisoner

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03308188